Stockwatch

Pascal Biosciences Inc
Symbol	PAS
Shares Issued	65,594,769
Close 2022-12-05	C$ 0.015
Market Cap	C$ 983,922
Recent Sedar Documents

Pascal investor McDermid acquires 78,000 shares

2023-02-03 10:25 ET - News Release

LeBlanc Subject: Pascal Biosciences Inc. (TSXV:PAS) - Press Release for Dissemination Word Document File: '\\swfile\EmailIn\20230203 071610 Attachment Press Release - E McDermid (Pascal Feb2023).docx' - 2 - DHP\12972-1\PRESS RELEASE - E MCDERMID (PASCAL FEB2023).DOCX PRESS RELEASE This press release is issued pursuant to National Instrument 62-104 - Take-Over Bids and Issuer Bids and National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. Vancouver, British Columbia - February 3, 2023 - Elaine McDermid, c/o Suite 530, 355 Burrard Street, Vancouver, British Columbia V6C 2G8, announces that on May 11, 2022, she acquired 78,000 common shares ("Common Shares") in the capital of Pascal Biosciences Inc. (the "Issuer") of 4000 Mason Road, Suite 304 Seattle, Washington, USA 98195, at a per share price of $0.04 per Common Share. Immediately before the transaction that triggered the requirement to file this news release, Ms. McDermid owned and/or exercised control or direction over an aggregate 6,503,500 Common Shares of the Issuer representing approximately 9.91% of the Issuer's then issued and outstanding Common Shares. Immediately after the transaction that triggered the requirement to file this news release, Ms. McDermid owned and/or exercised control or direction over an aggregate 6,581,500 Common Shares of the Issuer representing approximately 10.03% of the Issuer's then issued and outstanding Common Shares. As at the date of this news release, Ms. McDermid owns and/or exercises control or direction over an aggregate 6,785,500 Common Shares of the Issuer representing approximately 10.34% of the Issuer's issued and outstanding Common Shares. The Common Shares were acquired through the facilities of the TSX Venture Exchange at a per share price of $0.04 for total cash consideration of $3,120.00. The securities of the Issuer owned by or over which Ms. McDermid exercises direction or control, were acquired for investment purposes and Ms. McDermid will evaluate the investment in the Issuer and will increase or decrease the investment by future acquisitions or dispositions of securities of the Issuer at her discretion, as circumstances warrant. A report in this regard will be electronically filed with the securities regulator in each province where the Issuer is reporting and will be available for viewing through the Internet at the Canadian System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com. To obtain a copy of the report telephone (604) 605-4291. /s/ "Elaine McDermid" Elaine McDermid PDF Document File: Attachment Press Release - E McDermid (Pascal Feb2023).pdf PRESS RELEASE This press release is issued pursuant to National Instrument 62-104 Take-Over Bids and Issuer Bids and National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. Vancouver, British Columbia February 3, 2023 Elaine McDermid, c/o Suite 530, 355 Burrard Street, Vancouver, British Columbia V6C 2G8, announces that on May 11, 2022, she acquired 78,000 common shares ("Common Shares") in the capital of Pascal Biosciences Inc. (the "Issuer") of 4000 Mason Road, Suite 304 Seattle, Washington, USA 98195, at a per share price of $0.04 per Common Share. Immediately before the transaction that triggered the requirement to file this news release, Ms. McDermid owned and/or exercised control or direction over an aggregate 6,503,500 Common Shares of the Issuer representing approximately 9.91% of the Issuer's then issued and outstanding Common Shares. Immediately after the transaction that triggered the requirement to file this news release, Ms. McDermid owned and/or exercised control or direction over an aggregate 6,581,500 Common Shares of the Issuer representing approximately 10.03% of the Issuer's then issued and outstanding Common Shares. As at the date of this news release, Ms. McDermid owns and/or exercises control or direction over an aggregate 6,785,500 Common Shares of the Issuer representing approximately 10.34% of the Issuer's issued and outstanding Common Shares. The Common Shares were acquired through the facilities of the TSX Venture Exchange at a per share price of $0.04 for total cash consideration of $3,120.00. The securities of the Issuer owned by or over which Ms. McDermid exercises direction or control, were acquired for investment purposes and Ms. McDermid will evaluate the investment in the Issuer and will increase or decrease the investment by future acquisitions or dispositions of securities of the Issuer at her discretion, as circumstances warrant. A report in this regard will be electronically filed with the securities regulator in each province where the Issuer is reporting and will be available for viewing through the Internet at the Canadian System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com. To obtain a copy of the report telephone (604) 605-4291. /s/ "Elaine McDermid" Elaine McDermid